The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...

A Sun Sentinel reader speculates about why the deputy attorney general recently spent all that time with Ghislaine Maxwell In ...

North Carolina A&T Director of Athletics Earl M. Hilton III has named Kendall Cook as the new head coach of the Aggies ...

Discover key insights from Xenon Pharmaceuticals' Q2 2025 earnings call, including milestones in epilepsy, depression trials, and a strong cash ...

Belite Bio (BLTE) reports strong Q2 2025 progress on Tinlarebant trials for Stargardt's disease & geographic atrophy.

The FDA accepts a new drug application for vepdegestrant, a promising oral PROTAC developed by Arvinas and Pfizer, signaling ...

On Wednesday, Aug. 6, 2025, Governor Joe Lombardo signed AB 333 of the 83rd Legislative Session transferring the Nevada State ...

Treatments for acromegaly, edema, HSCT-associated thrombotic microangiopathy, multiple sclerosis, and spinal muscular atrophy are under review.

FDA accepts a new formulation of piflufolastat F 18, enhancing prostate cancer imaging access and efficiency, with a target ...

NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...

Danone has signed an NDA with Lifeway Foods to allow the French giant to weigh up whether to make another bid for the US kefir business.

A German company served a cease-and-desist letter to a US harm reductionist, claiming it owns the tech for the kits he's been ...